Press Release
March 8, 2023
Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg
More
February 28, 2023
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2022
More
February 22, 2023
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023
More
November 22, 2022
Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference
More
November 10, 2022
Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference
More
November 7, 2022
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022
More
October 28, 2022
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7, 2022
More
September 2, 2022
Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
More
August 16, 2022
Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Pre-Filled Syringes
More
August 8, 2022